Ignition Capital

PaxVax Corporation focuses on the research, development, manufacturing, and commercialization of vaccines targeting various infectious diseases. The company has developed a range of products, including a single-dose oral cholera vaccine (PXVX0200), a typhoid fever vaccine (Vivotif), and a hepatitis A vaccine (Epaxal). Additionally, PaxVax is advancing oral vaccine candidates for avian influenza, anthrax, and components for HIV vaccines, while also researching vaccines for malaria, dengue, rabies, and herpes simplex virus. By utilizing a proprietary adenoviral-based technology, PaxVax aims to overcome the limitations of traditional injectable vaccines, such as cold storage requirements and the need for medical personnel for administration. Founded in 2006 and headquartered in Redwood City, California, the company also has facilities in San Diego and Switzerland. PaxVax offers its vaccines for travelers and biodefense both in the United States and internationally, operating as a subsidiary of Emergent BioSolutions, Inc.

YPX Cayman Holdings Co., Ltd. is a restaurant management company based in Shanghai, China, specializing in the food and beverage industry. Established in 2010, the company operates a chain of restaurants under the brand name Cloud 9. In addition to its own brand, YPX Cayman Holdings aims to introduce new restaurant concepts into the Chinese market through franchising and partnerships with international companies. The company has set an ambitious goal of expanding its presence to approximately 1,500 stores across various brands in China. Its focus is on providing affordable, high-quality dining experiences, particularly in the realm of Taiwanese casual dining and snacks.

PaxVax Corporation focuses on the research, development, manufacturing, and commercialization of vaccines targeting various infectious diseases. The company has developed a range of products, including a single-dose oral cholera vaccine (PXVX0200), a typhoid fever vaccine (Vivotif), and a hepatitis A vaccine (Epaxal). Additionally, PaxVax is advancing oral vaccine candidates for avian influenza, anthrax, and components for HIV vaccines, while also researching vaccines for malaria, dengue, rabies, and herpes simplex virus. By utilizing a proprietary adenoviral-based technology, PaxVax aims to overcome the limitations of traditional injectable vaccines, such as cold storage requirements and the need for medical personnel for administration. Founded in 2006 and headquartered in Redwood City, California, the company also has facilities in San Diego and Switzerland. PaxVax offers its vaccines for travelers and biodefense both in the United States and internationally, operating as a subsidiary of Emergent BioSolutions, Inc.

PreViser has created simple to use, web enabled diagnostic and treatment planning decision support software for the care of patients with oral disease.

YPX Cayman Holdings Co., Ltd. is a restaurant management company based in Shanghai, China, specializing in the food and beverage industry. Established in 2010, the company operates a chain of restaurants under the brand name Cloud 9. In addition to its own brand, YPX Cayman Holdings aims to introduce new restaurant concepts into the Chinese market through franchising and partnerships with international companies. The company has set an ambitious goal of expanding its presence to approximately 1,500 stores across various brands in China. Its focus is on providing affordable, high-quality dining experiences, particularly in the realm of Taiwanese casual dining and snacks.

Tier 3 unleashes business agility through unique, enterprise-class cloud services and software that puts global companies on the path to IT as a Service. The company’s virtual private cloud services combine both infrastructure (IaaS) and platform as a service (PaaS) in a comprehensive platform. The Tier 3 Cloud increases IT operational efficiency and flexibility through advanced cloud orchestration and management capabilities. Global enterprises and service providers find the Tier 3 Cloud ideal for their entire business application portfolios, from development to production environments and mission-critical applications.

Spoken Communications specializes in providing a cloud-based contact center platform designed to enhance performance and customer outcomes. Their flagship product, Spoken ConversationCenter, is an AI-enabled solution that manages and analyzes various digital conversations, including voice interactions through their patented TrueMeaning technology. This platform allows service providers to efficiently meet the evolving demands of modern consumers by optimizing service delivery costs through the use of AI and Big Data. Spoken's system supports omnichannel communications, intelligent skills-based routing, and real-time transcription, which help improve agent performance and customer satisfaction. By enabling continuous improvement in contact center operations, Spoken Communications aims to redefine the customer experience while reducing the need for costly agent transfers.

Spoken Communications specializes in providing a cloud-based contact center platform designed to enhance performance and customer outcomes. Their flagship product, Spoken ConversationCenter, is an AI-enabled solution that manages and analyzes various digital conversations, including voice interactions through their patented TrueMeaning technology. This platform allows service providers to efficiently meet the evolving demands of modern consumers by optimizing service delivery costs through the use of AI and Big Data. Spoken's system supports omnichannel communications, intelligent skills-based routing, and real-time transcription, which help improve agent performance and customer satisfaction. By enabling continuous improvement in contact center operations, Spoken Communications aims to redefine the customer experience while reducing the need for costly agent transfers.